Efficacy of high dose consensus interferon for the treatment of chronic hepatitis C non responders to interferon alpha 2b and ribavirin.

被引：0
|
作者：
Moskovitz, DN [1 ]
Manoharan, P [1 ]
Heathcote, J [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1622
引用
收藏
页码：577A / 577A
页数：1
相关论文
共 50 条
  • [1] Efficacy of daily consensus interferon and ribavirin compared to PEG-interferon α-2b and ribavirin in non-responders with chronic Hepatitis C
    Dollinger, MM
    Dridi, Y
    Lesske, J
    Behl, S
    Fleig, WE
    [J]. HEPATOLOGY, 2005, 42 (04) : 691A - 692A
  • [2] High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C
    Moskovitz, DN
    Manoharan, P
    Heathcote, EJ
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (08): : 479 - 482
  • [3] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [4] Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.
    Glue, P
    Jen, F
    Gupta, SK
    Lau, G
    [J]. HEPATOLOGY, 1999, 30 (04) : 190A - 190A
  • [5] Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.
    Buggisch, P
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    Kueppers, H
    Wursthorn, K
    Sterneck, M
    [J]. HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [6] Prospective, randomized and controlled study of the efficacy of interferon alpha 2b plus ribavirin in chronic hepatitis C non-responders to prior interferon courses
    Moreno-Otero, R
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 166 - 167
  • [7] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [8] Combination treatment with consensus-interferon and ribavirin for chronic hepatitis C patients with non-response relapse to previous treatment with alpha-interferon and ribavirin.
    Buggisch, P
    Seegers, B
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    de Heer, G
    Wursthorn, K
    Sterneck, M
    [J]. HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [9] Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M.
    Wedemeyer H.
    Manns M.P.
    [J]. Current Gastroenterology Reports, 2002, 4 (1) : 23 - 30
  • [10] Prospective, randomized and controlled study of the efficacy and tolerance of Interferon alpha 2b plus Ribavirin in chronic hepatitis C non responders to prior Interferon courses.
    Otero, RM
    [J]. HEPATOLOGY, 2001, 34 (04) : 596A - 596A
12345